CHAPEL HILL, N.C., Feb. 25, 2026 (GLOBE NEWSWIRE) -- ACTG, a global clinical trials network focused on HIV and other infectious diseases, today announced the publication of "Tecovirimat for the ...
(MENAFN- GlobeNewsWire - Nasdaq) Study findings do not support routine use of tecovirimat in people with mpox CHAPEL HILL, N.C., Feb. 25, 2026 (GLOBE NEWSWIRE) -- ACTG, a global clinical trials ...
The MarketWatch News Department was not involved in the creation of this content. CHAPEL HILL, N.C., Feb. 25, 2026 (GLOBE NEWSWIRE) -- ACTG, a global clinical trials network focused on HIV and other ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results